Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 4:04 pm Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 4,970,899 9.500% | 19,596 (+0.40%) | Filing History |
| 2023-02-09 11:01 am Sale | 2023-01-31 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 2,593,524 4.900% | -25,094 (-0.96%) | Filing History |
| 2023-02-08 2:57 pm Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 2,618,618 5.000% | 2,618,618 (New Position) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 0 0.000% | -2,805,045 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 2,805,045 5.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing History |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,864,800 5.600% | -299,601 (-9.47%) | Filing History |
| 2022-02-11 5:04 pm Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Atlas Venture Fund XI, L.P. | 7,326,117 14.200% | -814,013 (-10.00%) | Filing History |
| 2022-02-04 09:17 am Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Wellington Management Group LLP | 1,763,053 3.420% | -1,141,669 (-39.30%) | Filing History |
| 2022-01-20 4:27 pm Purchase | 2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital, LP | 2,816,950 5.470% | 2,816,950 (New Position) | Filing History |
| 2021-08-16 2:37 pm Purchase | 2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 3,894,392 7.600% | 3,894,392 (New Position) | Filing History |
| 2021-02-16 5:28 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Atlas Venture Fund XI, L.P. | 8,140,130 17.900% | 8,140,130 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 2,805,045 6.200% | 2,805,045 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 3,164,401 7.000% | 218,450 (+7.42%) | Filing History |
| 2021-02-16 06:38 am Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Forbion Capital Fund IV Cooperatief U.A. | 6,131,079 13.490% | 6,131,079 (New Position) | Filing History |
| 2021-02-12 4:24 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 4,951,303 10.900% | 4,951,303 (New Position) | Filing History |
| 2021-02-03 3:11 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Wellington Management Group LLP | 2,904,722 6.390% | 2,904,722 (New Position) | Filing History |